IBRX Cash & Short-Term Investments
Immunitybio Inc · Cash & Short-Term Investments
IBRX Cash & Short-Term Investments
Latest reported$242.82Mperiod ending
IBRX FY Cash & Short-Term Investments ($350.00K → $242.82M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
IBRX cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 242,818,000 | |
| 149,809,000 | |
| 266,462,000 | |
| 107,184,000 | |
| 317,116,000 | |
| 96,061,000 | |
| 51,652,000 | |
| 74,149,000 | |
| 128,152,000 | |
| 198,921,000 | |
| 294,218,000 | |
| 59,104,000 | |
| 350,000 |